LPAR3

From WikiMD's WELLNESSPEDIA

LPAR3 or Lysophosphatidic Acid Receptor 3 is a protein that in humans is encoded by the LPAR3 gene. It is a member of the G protein-coupled receptor family and plays a crucial role in several biological processes, including cell proliferation, cell differentiation, and apoptosis.

Function[edit]

LPAR3 is a receptor for lysophosphatidic acid (LPA), a bioactive lipid mediator that influences various biological functions. LPA receptors are involved in many physiological and pathological processes, including embryo implantation, cell migration, neurogenesis, and cancer metastasis. LPAR3, in particular, has been implicated in the regulation of immune responses and inflammation.

Structure[edit]

The LPAR3 protein is a seven-transmembrane receptor, characteristic of the G protein-coupled receptor family. It is primarily located on the cell membrane, where it interacts with its ligand, LPA.

Clinical Significance[edit]

Alterations in the LPAR3 gene have been associated with several diseases, including ovarian cancer, asthma, and rheumatoid arthritis. In ovarian cancer, overexpression of LPAR3 has been linked to increased tumor aggressiveness and poor prognosis. In asthma and rheumatoid arthritis, variations in the LPAR3 gene may influence disease susceptibility and severity.

Research[edit]

Research on LPAR3 is ongoing, with studies focusing on its role in disease progression and potential as a therapeutic target. For example, drugs that block LPAR3 activity may be useful in treating conditions like ovarian cancer and inflammatory diseases.





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.